Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Hamlet BioPharma AB (publ) per 2025 Jun 30 adalah 0.21 MM.
- Nilai operating income untuk Hamlet BioPharma AB (publ) per 2025 Jun 30 adalah -55.13 MM.
- Nilai net income untuk Hamlet BioPharma AB (publ) per 2025 Jun 30 adalah -54.65 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 0.21 | -55.13 | -54.65 |
2025-03-31 | 0.18 | -49.21 | -48.70 |
2024-12-31 | -0.04 | -49.20 | -48.49 |
2024-09-30 | -0.01 | -44.14 | -43.25 |
2024-06-30 | -42.53 | -41.82 | |
2024-03-31 | 2.37 | -33.86 | -33.41 |
2023-12-31 | 2.38 | -26.86 | -26.59 |
2023-09-30 | 2.35 | -23.75 | -23.65 |
2023-06-30 | 2.34 | -20.54 | -20.44 |
2023-03-31 | 0.22 | -25.26 | -25.16 |
2022-12-31 | 1.39 | -24.13 | -24.03 |
2022-09-30 | 6.03 | -20.77 | -20.77 |
2022-06-30 | 9.96 | -17.12 | -17.20 |
2022-03-31 | 13.02 | -9.75 | -10.05 |
2021-12-31 | 13.25 | -7.75 | -8.05 |
2021-09-30 | 10.24 | -7.63 | -7.93 |
2021-06-30 | 9.31 | -7.50 | -7.72 |
2021-03-31 | 6.45 | -13.49 | -13.49 |
2020-12-31 | 5.08 | -17.37 | -17.37 |
2020-09-30 | 3.44 | -22.53 | -22.53 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.24 | -0.24 |
2024-12-31 | -0.25 | -0.25 |
2024-09-30 | -0.24 | -0.24 |
2024-06-30 | -0.25 | -0.25 |
2024-03-31 | -0.27 | -0.27 |
2023-12-31 | -0.22 | -0.22 |
2023-09-30 | -0.20 | -0.20 |
2023-06-30 | -0.18 | |
2023-03-31 | -0.22 | -0.22 |
2022-12-31 | -0.22 | -0.22 |
2022-09-30 | -0.19 | -0.19 |
2022-06-30 | -0.16 | |
2022-03-31 | -0.09 | -0.09 |
2021-12-31 | -0.08 | -0.08 |
2021-09-30 | -0.08 | -0.08 |
2021-06-30 | -0.08 | |
2021-03-31 | -0.13 | -0.13 |
2020-12-31 | -0.17 | -0.17 |
2020-09-30 | -0.22 | -0.22 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Hamlet BioPharma AB (publ) per 2025 Jun 30 adalah -38.83 MM.
- Nilai cash from investing activities untuk Hamlet BioPharma AB (publ) per 2025 Jun 30 adalah -0.02 MM.
- Nilai kas dari aktivitas pendanaan untuk Hamlet BioPharma AB (publ) per 2025 Jun 30 adalah 26.51 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -38.83 | -0.02 | 26.51 |
2025-03-31 | -39.66 | -0.17 | 28.28 |
2024-12-31 | -41.38 | -0.17 | 65.74 |
2024-09-30 | -35.60 | -0.28 | 39.22 |
2024-06-30 | -36.00 | -0.28 | 40.99 |
2024-03-31 | -28.81 | -10.11 | 47.59 |
2023-12-31 | -21.75 | -10.11 | 10.13 |
2023-09-30 | -19.87 | -9.97 | 10.13 |
2023-06-30 | -19.61 | -9.97 | 8.37 |
2023-03-31 | -23.14 | 5.52 | |
2022-12-31 | -23.44 | 5.52 | |
2022-09-30 | -22.72 | 5.52 | |
2022-06-30 | -20.32 | 52.46 | |
2022-03-31 | -12.73 | 46.93 | |
2021-12-31 | -10.79 | 46.93 | |
2021-09-30 | -9.90 | 46.93 | |
2021-06-30 | -5.77 | ||
2021-03-31 | -14.70 | 0.00 | |
2020-12-31 | -14.83 | 12.94 | |
2020-09-30 | -17.85 | 25.87 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -0.80.
- roe untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -0.85.
- roic untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -1.50.
- croic untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -0.34.
- ocroic untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -1.07.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.80 | -0.85 | -1.50 | -0.34 | -1.07 |
2025-03-31 | -0.60 | -0.64 | -0.90 | -0.21 | -0.74 |
2024-12-31 | -0.68 | -0.79 | -0.80 | 0.06 | -0.66 |
2024-09-30 | -0.68 | -0.79 | -0.80 | 0.06 | -0.66 |
2024-06-30 | -1.36 | -1.61 | -0.44 | 0.11 | -0.38 |
2024-03-31 | -0.89 | -1.02 | |||
2023-12-31 | -0.69 | -0.73 | -0.43 | -0.36 | -0.36 |
2023-09-30 | -0.49 | -0.54 | -0.98 | -1.01 | -0.94 |
2023-06-30 | -0.49 | -0.54 | -0.98 | -1.01 | -0.94 |
2023-03-31 | -0.59 | -0.62 | -1.22 | -0.85 | -1.12 |
2022-12-31 | -0.39 | -0.44 | -0.64 | -0.53 | -0.70 |
2022-09-30 | -0.39 | -0.44 | -0.64 | -0.53 | -0.70 |
2022-06-30 | -1.35 | -6.24 | -0.45 | 0.85 | -0.53 |
2022-03-31 | -0.88 | -2.91 | -0.25 | 0.85 | -0.32 |
2021-12-31 | -0.38 | -0.92 | -0.17 | 0.78 | -0.21 |
2021-09-30 | -0.38 | -0.92 | -0.17 | 0.78 | -0.21 |
2021-06-30 | -0.53 | -0.74 | -0.88 | -0.66 | -0.66 |
2021-03-31 | -0.60 | -0.80 | -3.90 | -4.25 | -4.25 |
2020-12-31 | -3.71 | -4.26 | -2.61 | 0.93 | -2.07 |
2020-09-30 | -3.71 | -4.26 | -2.61 | 0.93 | -2.07 |
Gross Margins
- marjin kotor untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah 1.00.
- marjin bersih untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -262.71.
- marjin operasi untuk Hamlet BioPharma AB (publ) pada 2025 Jun 30 adalah -264.98.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 1.00 | -262.71 | -264.98 |
2025-03-31 | 1.00 | -273.47 | -276.35 |
2024-12-31 | 1.00 | 5,081.98 | 5,186.74 |
2024-09-30 | 1.00 | 5,081.98 | 5,186.74 |
2024-06-30 | 1.00 | -14.11 | -14.30 |
2024-03-31 | 1.00 | -11.19 | -11.30 |
2023-12-31 | 1.00 | -9.73 | -9.77 |
2023-09-30 | 1.00 | -8.44 | -8.48 |
2023-06-30 | 1.00 | -8.44 | -8.48 |
2023-03-31 | 1.00 | -112.66 | -113.09 |
2022-12-31 | 1.00 | -3.44 | -3.44 |
2022-09-30 | 1.00 | -3.44 | -3.44 |
2022-06-30 | 1.00 | -1.72 | -1.72 |
2022-03-31 | 1.00 | -0.77 | -0.75 |
2021-12-31 | 1.00 | -0.77 | -0.74 |
2021-09-30 | 1.00 | -0.77 | -0.74 |
2021-06-30 | 1.00 | -0.83 | -0.80 |
2021-03-31 | 1.00 | -2.09 | -2.09 |
2020-12-31 | 1.00 | -6.55 | -6.55 |
2020-09-30 | 1.00 | -6.55 | -6.55 |